Preologi Ltd.
SCVC has partnered with Preologi to become one of the first UK clinics to offer the new Galleri multi-cancer early detection test. A single blood sample can screen for over 50 cancers, and this test can increase cancer detection by 6.5x when compared to conventional US cancer screening programs. False positive rates are low, at less than 1/200. The test is particularly effective at detecting cancers of the pancreas, stomach, esophagus, and colorectum. This test is now widely used in the US at leading centres such as The Mayo Clinic, The Cleveland Clinic, Duke University, and Cedars-Sinai, among many others. The test has undergone large-scale clinical trials involving over 300,000 participants.